The Ascom Healthcare Platform software captures, tracks, and records vital signs, alarms, and other data from patient-room equipment, ICUs, operating rooms, and other wards. Information is continuously analyzed and presented as meaningful data in a controlled, secure manner to the right person or system at the right time and at the right place, resulting in faster responses to individual patient events. “Because time is of the essence when

treating sepsis,” said Janney, “Ascom’s Clinical Consulting Service and portfolio of products, such as the Ascom Myco smart phone with the Unite Context clinical col- laboration application, allow hospital staff members to communicate and collaborate at a time when speed is critical.” Rhonda Collins, Chief Nursing Officer, Vocera Communications, agreed, saying, “Time is of the essence when diagnosing and treating sepsis. Real-time communication between clinicians is critical. To help care teams identify sepsis sooner and initiate treatment quicker, Vocera technology can integrate with a hospital’s electronic health records system and predictive analytics tool.”

Collins provid-

ed an example of how their product works to thwart sepsis. “At Halifax Health in Florida, Vocera teamed up with Wolters Klu- wer Health to arm care teams with a high-powered sep- sis surveillance and alerting solution.

The Vocera Platform

on the right course of treatment. It does that accurately, early, and effectively.” “Identification and communication are key to expediting diagnosis of sepsis,” de- clared Tim O’Malley, President, EarlySense Inc. “For every hour a patient is septic, their mortality rate will increase by almost 8 percent; therefore, any infection needs to be determined earlier and treatment initiated. As time goes by, acuity of these patients increases. Left undiagnosed and untreated, these patients will become more complex, requiring more time in a higher acuity environment.” O’Malley explained that the EarlySense System is a contact-free, continu- ous monitoring system employing a small sensor under the patient’s mattress that collects the heart rate and respiratory rate twice per second. “The goal of the EarlySense System is to identify the earliest warning signs, so providers can expedite action, diagnosis, and treatment. One of the first signs of infection, and concurrently sepsis, is an increase in these key vital signs,” said O’Malley. “This system helps alert clinicians that a patient is experiencing an increase in heart rate and respiratory rate and should be evaluated. We introduced a multi-parameter alert recently that warns caregivers if heart rate combined with respiratory rate is elevated over a period of time. If both of these parameters are elevated for, say, 4 hours, it merits a check of other param- eters to determine if the patient is developing a more advanced

Wolters Kluwer’s POC Advisor analyzes 250+ data points within a patient’s medi- cal record to identify early signs of sepsis, warn caregivers of escalating risks, and empower them with evidence-based guid- ance at the point of care. When early signs of an infection are detected, an alert with situational information is sent directly to the patient’s care-team members via their Vocera badges and smartphone apps. This clinical workflow and proactive com- munication can result in faster diagnoses and treatment of sepsis, which leads to reduced severity, decreased mortality, and lower costs.” Steve Claypool, MD, Medical Director for Wolters Kluwer Clinical Software Solutions, con- curred. “POC Advisor can detect and alert the clinical staff to sepsis cases faster and provide guidance

infection or is pre-septic.” In a study of more than 7,000 patient outcomes, using the EarlySense System, the number of ICU days for transferred patients decreased by 46 percent, the overall hospital length of stay decreased by 9 percent in the intervention group, and the number of code-blue events decreased by 86 percent,

all because patients were treated as soon as they began to deteriorate.3 Chan, CytoSorbents, highlighted the importance of all healthcare professionals being alert to sepsis, “particularly when pa- tients have signs and symptoms of infection, exhibit fever, or have instability, especially concerning blood pressure, oxygenation, or kidney function. CytoSorbents’ CytoSorb blood-purification technology is designed to control the deadly inflammation that kills patients in severe sepsis and septic shock, helping to round out the spectrum of treat- ment approaches for sepsis that include rapid detection, antibiotics, supportive-care therapy, and active con- trol of inflammation.”

BD BACTEC FX series automated blood culture instrument

BD BACTEC blood culture media

Blood cultures are an important compo-

nent in diagnosing sepsis. “A key compo- nent is promoting best practices in blood culturing and offering proven performance in the diagnosis of sepsis,” stated Casados. “BD’s integrated blood-culture solution includes the BD BACTEC blood-culture media, BD BACTEC FX Series Automated Blood Culture Instrument, and the BD Syna- psys informatics solution. BD recognizes the key role of data-management solutions in measuring quality metrics and workflow efficiencies. BD Synapsys Microbiology Informatics Solution connects data from BD blood-culture instruments in disparate systems and settings, which expedites com- munication to clinicians and pharmacists, facilitating accurate, timely diagnosis and appropriate therapy for patients.”

EarlySense System

Connecting the dots between sepsis and readmissions The Centers for Medicare and Medicaid are required to reduce payments to certain hospitals that have excessive readmissions within 30 days of the patient’s dismissal,4


it is vital that sepsis patients are stable be- fore leaving the hospital. Abban, VigiLanz, cited some readmission statistics. “More than 12 percent of all unplanned 30-day readmissions are associated with a sepsis

Page 26 • HEALTHCARE PURCHASING NEWS • April 2018 25

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62